Vanderbilt and AstraZeneca: partnering to help patients with major brain disorders

Our research collaboration with the Vanderbilt Center for Neuroscience Drug Discovery aims to identify candidate drugs for treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

Together, we hope to enable breakthrough discoveries and bring new medicines to patients suffering from these diseases.

Related articles